Advocates on Steps of Congress 2013
Please leave this field empty
Scleroderma Foundation
Homepage | Forward to a Friend | Make a Donation
eletter banner.jpg
eLetter #684 | November 11, 2016  

Cytori, Genentech to Present Scleroderma Research Trial Information at ACR Meeting

Cytori Therapeutics, Inc. will present data from its STAR Phase 3 clinical trial describing progress, preliminary blinded patient characteristics, and safety of adipose-derived regenerative cells (ADRCs) for treatment of scleroderma hand dysfunction (clinicaltrials.gov) at the Annual Meeting of the American College of Rheumatology on November 15, 2016.

Read the full press release >>

Genentech, a member of the Roche Group announced that new data from Actemra (tocilizumab) and Rituxan (rituximab) will be presented during the 2016 American College of Rheumatology (ACR) and Association for Rheumatology Health Professionals (ARHP) Annual Meeting, November 11-16, Washington, D.C. These data add to the significant body of evidence for Actemra and Rituxan in RA and other serious immune-mediated conditions including GCA, systemic sclerosis (SSc), granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).

Learn more about this data >>

Meet the Scleroderma Foundation Staff at ACR

Members of the Scleroderma Foundation's National Office will be attending the ACR annual meeting November 11-16, 2016, in Washington, D.C. Please stop by booth No. 1241 in the Exhibit Hall.

Learn more about the ACR annual meeting >>

Simple Workout Routines for People with Chronic Pain

walking.jpgThe Arthritis Foundation provides several different simple workout routines for people living with arthritis and chronic pain. These workouts include stretching, water aerobics, circuit training, weight lifting, and more.

Learn more about exercise routines >>

Video: Hematopoietic Stem Cell Transplants

Stem Cell

In this video, Dr. Richard Burt talks about hematopoietic stem cell transplantation as it relates to scleroderma. He also discusses transplantation for autoimmune and immune mediated diseases.

Watch the entire session >>

#GIVINGTUESDAY?

Giving TuesdayPlease consider a gift to the Scleroderma Foundation on November 29, 2016 in the spirit of #GivingTuesday and help us #FUNDTHECURE!  You can help us continue the vital work of research by making a gift to the Scleroderma Foundation.  

We have a day for giving thanks. We have two for getting deals. Now, we have #GivingTuesday, a global day dedicated to giving back. On Tuesday, November 29, 2016, charities, families, businesses, community centers, and students around the world will come together for one common purpose: to celebrate generosity and to give.

#GivingTuesday challenges individuals and communities to make the world a better place through generosity.  The simple act of giving not only helps others, but also fundamentally connects you to the human family and nourishes a generous community spirit. 

Making your gift is easy! Visit www.scleroderma.org/givingtuesday or call us at 800-722-HOPE (4673). 

 
Quick Links
Advocacy
Contact Us
Become a Member
About Scleroderma
Calendar of Events
Online Chat
Store
Home
facebook_32.png
twitter_32.png
2016 Instagram
Youtube_32x32.png

Giving Tuesday
Actelion 2016 sponsor
2016 Bayer Logo
2016 Bronze National Sponsor Reata
2016 Gilead Silver Conference Sponsor
Genentech
United Therapeutics Logo
 

 

Advertisement

Sencis Ad - eLetter

Disclaimer: The Scleroderma Foundation in no way endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.

Powered by Blackbaud  Unsubscribe | Visit our web site | Contact Us | Donate
300 Rosewood Drive, Suite 105, Danvers, MA 01923 tel: 800-722-HOPE (4673)
© 2017 All rights reserved.